Astria Therapeutics Statistics

Total Valuation

ATXS has a market cap or net worth of $294.02 million. The enterprise value is -$28.76 million.

Market Cap	294.02M
Enterprise Value	-28.76M

Important Dates

The next estimated earnings date is Thursday, May 8, 2025, after market close.

Earnings Date	May 8, 2025
Ex-Dividend Date	n/a

Share Statistics

ATXS has 56.43 million shares outstanding. The number of shares has increased by 86.44% in one year.

Current Share Class	56.43M
Shares Outstanding	56.43M
Shares Change (YoY)	+86.44%
Shares Change (QoQ)	+0.34%
Owned by Insiders (%)	0.47%
Owned by Institutions (%)	64.63%
Float	33.97M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	1.31
P/TBV Ratio	1.31
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 17.49, with a Debt / Equity ratio of 0.02.

Current Ratio	17.49
Quick Ratio	17.15
Debt / Equity	0.02
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -33.52% and return on invested capital (ROIC) is -24.55%.

Return on Equity (ROE)	-33.52%
Return on Assets (ROA)	-23.36%
Return on Invested Capital (ROIC)	-24.55%
Return on Capital Employed (ROCE)	-34.51%
Revenue Per Employee	n/a
Profits Per Employee	-$1.21M
Employee Count	78
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -45.95% in the last 52 weeks. The beta is 0.68, so ATXS's price volatility has been lower than the market average.

Beta (5Y)	0.68
52-Week Price Change	-45.95%
50-Day Moving Average	5.78
200-Day Moving Average	9.21
Relative Strength Index (RSI)	53.18
Average Volume (20 Days)	476,485

Short Selling Information

The latest short interest is 2.86 million, so 5.06% of the outstanding shares have been sold short.

Short Interest	2.86M
Short Previous Month	3.19M
Short % of Shares Out	5.06%
Short % of Float	8.41%
Short Ratio (days to cover)	9.82

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-111.56M
Pretax Income	-81.63M
Net Income	-94.26M
EBITDA	n/a
EBIT	-111.56M
Earnings Per Share (EPS)	-$1.68

Full Income Statement

Balance Sheet

The company has $328.13 million in cash and $5.35 million in debt, giving a net cash position of $322.78 million or $5.72 per share.

Cash & Cash Equivalents	328.13M
Total Debt	5.35M
Net Cash	322.78M
Net Cash Per Share	$5.72
Equity (Book Value)	319.26M
Book Value Per Share	3.97
Working Capital	315.51M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$81.21 million and capital expenditures -$325,000, giving a free cash flow of -$81.54 million.

Operating Cash Flow	-81.21M
Capital Expenditures	-325,000
Free Cash Flow	-81.54M
FCF Per Share	-$1.44

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

ATXS does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-86.44%
Shareholder Yield	-86.44%
Earnings Yield	-32.06%
FCF Yield	-27.73%

Analyst Forecast

The average price target for ATXS is $26.60, which is 410.56% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$26.60
Price Target Difference	410.56%
Analyst Consensus	Strong Buy
Analyst Count	5
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-42.89%

Stock Forecasts

Stock Splits

The last stock split was on August 20, 2021. It was a reverse split with a ratio of 0.1666667:1.

Last Split Date	Aug 20, 2021
Split Type	Reverse
Split Ratio	0.1666667:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	1